Abstract
Despite the efficacy of antibiotics as well as bacteriophages in treatment of bacterial infections, their role in treatment of biofilm associated infections is still under consideration especially in case of older biofilms. Here, efficacy of bacteriophage alone or in combination with amoxicillin, for eradication of biofilm of Klebsiella pneumoniae B5055 has been assessed. Planktonic cells as well as biofilm of K. pneumoniae B5055 grown in 96-well microtiter plates were exposed to bacteriophage and amoxicillin at various Multiplicity of Infections (MoIs) as well as at three different antibiotic concentrations (512, 256 and 128 μg/ml), respectively. After exposure to 256 μg/ml (MIC) of amoxicillin, bacterial load of planktonic culture as well as 1-day-old biofilm was reduced by a log factor of 4.1 ± 0.31 (P = 0.008) and 1.24 ± 0.27 (P < 0.05), respectively but reduction in the bacterial load of mature biofilm (8-day-old) was insignificant (P = 0.23). When 8-day-old biofilm was exposed to higher antibiotic concentration (512 μg/ml) or phage alone (MoI = 0.01) a log reduction of 2.97 ± 0.11 (P = 0.182) and 3.51 ± 0.19 (P = 0.073), respectively was observed. While on exposing to a combination of both the amoxicillin and phage, a significant reduction (P < 0.01) in bacterial load of the biofilm was seen. Hence, when antibiotic was used in combination with specific bacteriophage a greater destruction of the biofilm structure suggested that the phages could be used successfully along with antibiotic therapy. An added advantage of the combination therapy would be its ability to check formation of resistant mutants that otherwise develop easily upon using phage or antibiotic alone.
Similar content being viewed by others
References
Adam MH (1959) “Lysogeny” in bacteriophages. Interscience Publishers, Inc., London, pp 365–380
Alisky J, Iczkowski K, Rapoport A, Troitsky N (1998) Bacteriophages show promise as antimicrobial agents. J Infect 36:5–15. doi:10.1016/S0163-4453(98)92874-2
Anderl JN, Franklin MJ, Stewart PS (2000) Role of Antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 44:1818–1824. doi:10.1128/AAC.44.7.1818-1824.2000
Anderl JN, Jeff Z, Frank R, Stewart PS (2003) Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 47:1251–1256. doi:10.1128/AAC.47.4.1251-1256.2003
Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48:5–16. doi:10.1093/jac/48.2.322
Christensen BE (1985) The role of extracellular polysaccharides in biofilms. J Biotechnol 10:181–202. doi:10.1016/0168-1656(89)90064-3
Dickinson M, Bisno AL (1993) Infections associated with prosthetic devices: clinical considerations. Int J Artif Organs 16:749–754
Donlan RM (2001) Biofilms and device-associated infections. www.cdc.gov/ncidod/EiD/vol7no2/donlan.html
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193. doi:10.1128/CMR.15.2.167-193.2002
Evans DJ, Allison DG, Brown MRW, Gilbert P (1991) Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J Antimicrob Chemother 27:177–184. doi:10.1093/jac/27.2.177
Finelli AC, Gallant V, Jarvi K, Burrows LL (2003) Use of in-biofilm expression technology to identify genes involved in Pseudomonas aeruginosa biofilm development. J Bacterial 185:2700–2710
Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34–40. doi:10.1016/j.tim.2004.11.010
Gill JJ, Pacan JC, Carson ME, Leslie KE, Griffiths MW, Sabour PM (2005) Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob Agents Chemother 50:2912–2918. doi:10.1128/AAC.01630-05
Górski A, Weber-Dabrowska B (2005) The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci 62:511–519. doi:10.1007/s00018-004-4403-6
Hughes KA, Sutherland IW, Clark J, Jones MV (1998a) Bacteriophage and associated polysaccharide depolymerases—novel tools for study of bacterial biofilms. J Appl Microbiol 85:583–590. doi:10.1046/j.1365-2672.1998.853541.x
Hughes KA, Sutherland IW, Clark J, Jones MV (1998b) Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144:3039–3047
Jagnow J, Clegg S (2003) Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces. Microbiol 149:2397–2405. doi:10.1099/mic.0.26434-0
Jefferson KK (2004) What drives bacteria to produce a biofilm? FEMS Microbiol Lett 236:163–173
Langstraat J, Bohse M, Clegg S (2001) Type 3 fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the fimbrial adhesin (MrkD), facilitates biofilm formation. Infect Immun 69:5805–5812. doi:10.1128/IAI.69.9.5805-5812.2001
Lewis K (2007) Persister cells, dormancy and infectious disease. Nature 5:48–56
Mah TF, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34–39. doi:10.1016/S0966-842X(00)01913-2
Matz C, Kjelleberg S (2005) Off the hook—how bacteria survive protozoan grazing. Trends Microbiol 13:302–307. doi:10.1016/j.tim.2005.05.009
National Committee for Clinical Laboratory Standards (2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A5. NCCLS, Villanova
Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ (2008) Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J Appl Microbiol 104:1–13
Raad I (1998) Intravascular-catheter-related infections. Lancet 351:893–898. doi:10.1016/S0140-6736(97)10006-X
Stewart PS, Costerton JW (2003) Antibiotic resistance of bacteria in biofilms. Lancet 358:135–138. doi:10.1016/S0140-6736(01)05321-1
Suci PA, Mittelman MW, Yu FP, Geesey GG (1994) Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 38:2125–2133
Sulakvelidze A (2005) Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. Drug Discov Today 12:807–809. doi:10.1016/S1359-6446(05)03441-0
Sutherland I (2001) Biofilm exopolysaccharides: a strong and sticky framework. Microbiology 147:3–9
Sutherland IW, Wilkinson JF (1965) Depolymerases for bacterial EPS obtained from phage-infected bacteria. J Gen Microbiol 39:373–383
Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A (1986) The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol 132:1297–1304
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bedi, M.S., Verma, V. & Chhibber, S. Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World J Microbiol Biotechnol 25, 1145–1151 (2009). https://doi.org/10.1007/s11274-009-9991-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-009-9991-8